Biomarker evidence assessment and prioritization
Weigh the scientific strength, consistency and clinical relevance of candidate biomarkers before committing resources.
Services
Evidence Assessment for Specific R&D Decisions
Support for biomarker, target, clinical, pathway and workflow decisions. Each scope is defined by the question and evidence required.
Drug-target discovery and validation support
Structure the published and clinical evidence around a target, and surface where validation is still thin.
Clinical-trial and scientific landscape analysis
See who is studying what, with which endpoints and populations, and where the whitespace sits.
Disease-mechanism and biological pathway mapping
Connect mechanisms, pathways and readouts into a map your team can reason about together.
Competitive and technology intelligence
Track scientific and technological movement around your programme without drowning in alerts.
R&D workflow gap and bottleneck analysis
Locate the steps where evidence, data or decisions stall, and what would unblock them.
Customized scientific intelligence reports
A report shaped around one decision, written for both scientific and business stakeholders.
Outputs your team can review and use
Each deliverable links evidence quality and uncertainty to the decision being assessed.
- Evidence maps
- Biomarker and target comparison matrices
- Clinical-trial landscape summaries
- Scientific gap and opportunity assessments
- Risk and uncertainty analysis
- Prioritized recommendations
- Customized scientific intelligence reports
- Clear visual summaries for scientific and business stakeholders
Describe the scientific decision, available evidence and current bottleneck.
Start a scientific inquiry